Conclusions Pharmacotherapy for pediatric obesity has advanced rapidly in recent years, offering new hope for children and adolescents who do not achieve sufficient weight reduction with lifestyle interventions alone
[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Edens NK, Leibel RL, Hirsch J
Months earlier, it abandoned another oral obesity drug that showed concerning liver effects in a trial
The GLP-1 analogues market is shifting from first-generation appetite and glucose control toward next-generation metabolic disease modification
Consumers today are looking for foods that do more and deliver benefits they really need, said Kerry DeLaney, CEO of Midwest Yogurt, a division of Lactalis USA
When combined with potentially reduced food intake due to decreased appetite, you may not be getting enough fiber in your diet, further exacerbating constipation issues